Director, MS&T for Radiopharmaceutical Operations Indianapolis - RayzeBio - IN R1605577 Posted 18 hours ago

At Rayze Bio, every day is an opportunity to ignite meaningful change. As a wholly-owned subsidiary of Bristol Myers Squibb, Rayze Bio blends the nimble, pioneering spirit of an emergent biotech with the global expertise and resources of a leading innovator in oncology. Our mission is to develop transformative radiopharmaceutical therapies that offer new hope for patients living with cancer. Here, you’ll join a multidisciplinary team where your ideas are valued, your expertise is amplified, and collaboration is at the heart of everything we do.

From day one, expect to make an immediate impact—on our science, on our teams, and most importantly, on patients. Learn more about Rayze Bio:

The Director of MS&T will provide strategic and technical leadership for commercial-stage manufacturing process ownership, technology transfer, process validation, and lifecycle management at the BMS Indianapolis Radiopharmaceutical Manufacturing Site. This role is accountable for all MS&T activities from the point of transition from Product Development — encompassing late-phase scale-up, commercial process technical leadership, technology transfer, process validation (Stages 1–3), and post-approval changes (SUPAC) — through the full commercial lifecycle of each product.

This role serves as the primary technical SME and inspection readiness leader for GMP manufacturing at the Indianapolis site, driving rigorous technology transfer, process characterization, process validation, continued process verification (CPV), and sustained inspection readiness. The Director drives cross-functional collaboration across R&D/CMC, Quality, Operations, Regulatory Affairs, Supply Chain, and external CDMOs to ensure site capabilities support clinical and commercial program milestones, while maintaining ownership of the site's manufacturing science strategy, CMC regulatory support, process validation lifecycle, deviation and CAPA leadership, and sustained inspection readiness.

Essential duties and responsibilities include the following. Other duties may be assigned.

• Own and lead all technology transfer activities post R&D/CMC to Indianapolis, Indianapolis-to-CDMO, CDMO-to-Indianapolis, and reverse transfers as the single accountable leader for planning, execution, documentation, risk management, and completion; govern comprehensive transfer plans defining scope, timelines, milestones, success criteria, and risk mitigation for each transfer event
• Lead late Phase 2/Phase 3 and commercial-scale transfers translating development-stage processes into robust, GMP-ready manufacturing processes; direct site-to-CDMO transfers packaging all process knowledge, batch records, and validation data for contract partners; own CDMO-to-Indianapolis reverse transfers ensuring full traceability, comparability, and operational readiness per ICH Q12; serve as the primary technical interface with CDMOs, managing relationships, reviewing deliverables, and ensuring alignment with BMS quality and regulatory standards
• Own and enforce VHP material compatibility review as a mandatory transfer gate, ensuring all materials, consumables, product contact surfaces, and equipment are confirmed VHP-compatible prior to GMP use.
• Conduct site readiness and gap assessments evaluating equipment capability, facility requirements and documentation gaps prior to each transfer; ensure analytical infrastructure alignment is confirmed in coordination with AS&T prior to each transfer event
• Lead MS&T throughout the manufacturing process development and continuous improvement for all commercial and late-phase clinical manufacturing processes at the Indianapolis site; ensuring that his organization maintain deep ownership of process understanding, process robustness, yield optimization, appearance/presentation standards, and technology performance across the product lifecycle; lead process characterization studies to establish design space, identify process sensitivities, and support regulatory filings — including characterization protocol authorship, execution, data analysis, and reporting
• Lead the MS&T organization throughout the process optimization…